Back to Journals » Breast Cancer: Targets and Therapy » Volume 3

Review

Clinical utility of the combination of lapatinib and letrozole in the management of hormone receptor-positive and HER2-positive advanced breast cancer

       
Total article views   HTML views PDF downloads Totals
9,628 Dovepress* 9,070+ 2,222 11,292
PubMed Central* 558 187 745
Totals 9,628 2,409 12,037
*Since 26 October 2011
+Since July 2016

View citations on PubMed Central and Google Scholar